TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32634820

Group type: EXPERIMENTAL
Intervention: Reports on infant body composition available to clinicians
Number of subjects: 50

Group type: COMPARATOR
Intervention: No reports on infant body composition available to clinicians (Control)
Number of subjects: 50
Study: 33660001

Group type: EXPERIMENTAL
Intervention: Physiotherapist-supervised pelvic floor muscle (PFM) training
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (standard care - handout)
Number of subjects: 103
Study: 33507592

Group type: EXPERIMENTAL
Intervention: 750 mg/kg/d of standardized extract of Nasturtium officinale (SENO)
Number of subjects: 34

Group type: COMPARATOR
Intervention: 750 mg/kg/d of placebo
Number of subjects: 34
Study: 35998251

Group type: EXPERIMENTAL
Intervention: Rest-Pause (RP): 3 × 16 repetitions at 75% 1RM
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Drop-Set (DS): 3 × 10 repetitions at 75% with 6 additional repetitions at 55% 1RM
Number of subjects: 27

Group type: COMPARATOR
Intervention: Traditional (TRAD): 4 × 12 repetitions at 70% 1RM
Number of subjects: 27
Study: 33693639

Group type: EXPERIMENTAL
Intervention: Standardized orientation programme inclusive of environmental cues
Number of subjects: 40
Study: 32159257

Group type: EXPERIMENTAL
Intervention: Garlic supplement (500 mg, 2 tablets daily for 8 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (2 tablets daily for 8 weeks)
Number of subjects: 70
Study: 34582088

Group type: EXPERIMENTAL
Intervention: Combination therapy using non-ablative fractional laser and intralesional triamcinolone injection
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (non-treatment)
Number of subjects: 64
Study: 33704569

Group type: EXPERIMENTAL
Intervention: Er:YAG laser therapy (n = 19)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser therapy (n = 15)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Er:YAG + Nd:YAG combination therapy (n = 20)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Scalpel excision (control group, n = 21)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All HLLT groups (Er:YAG, Nd:YAG, Er:YAG + Nd:YAG)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All study groups (including control)
Number of subjects: 75
Study: 32445434

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 0
Study: 36102261

Group type: EXPERIMENTAL
Intervention: Elective PCI after COURAGE trial (2007)
Number of subjects: 1245802

Group type: EXPERIMENTAL
Intervention: Elective PCI after ORBITA trial (2017)
Number of subjects: 1245802

Group type: EXPERIMENTAL
Intervention: Elective PCI without angina symptoms
Number of subjects: 1245802

Group type: EXPERIMENTAL
Intervention: Elective PCI rates per year
Number of subjects: 1245802

Group type: EXPERIMENTAL
Intervention: Elective PCI rates per 100,000 population
Number of subjects: 1245802
Study: 33749762

Group type: EXPERIMENTAL
Intervention: Patients aged >70 years
Number of subjects: 5922

Group type: COMPARATOR
Intervention: Patients aged ≤70 years
Number of subjects: 5922

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 5922

Group type: EXPERIMENTAL
Intervention: Patients aged >70 years vs ≤70 years
Number of subjects: 5922

Group type: EXPERIMENTAL
Intervention: Age >70 years
Number of subjects: 5922

Group type: EXPERIMENTAL
Intervention: Age groups comparison
Number of subjects: 5922
Study: 35113140

Group type: EXPERIMENTAL
Intervention: 3D viewing group
Number of subjects: 46

Group type: COMPARATOR
Intervention: 2D viewing group
Number of subjects: 46
Study: 37842338

Group type: EXPERIMENTAL
Intervention: Cash grant of 500 USD
Number of subjects: 2177

Group type: EXPERIMENTAL
Intervention: Cash grant of 500 USD (males)
Number of subjects: 2177

Group type: EXPERIMENTAL
Intervention: Cash grant of 500 USD (females)
Number of subjects: 2177

Group type: EXPERIMENTAL
Intervention: Mentorship
Number of subjects: 2177
Study: 32335288

Group type: EXPERIMENTAL
Intervention: Take a Break intervention including Motivational Messages, text message Challenge Quizzes, Goal-setting with tobacco treatment specialist, Coping Mini-Games apps, Recognition and Rewards for participation during a 3-week challenge.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brief Nicotine Replacement Therapy (NRT) sampling and daily smoking assessment text messages for three weeks.
Number of subjects: 0
Study: 36307161

Group type: EXPERIMENTAL
Intervention: Thoracoscopic left atrial appendage closure (LAAC)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Novel oral anticoagulants (NOACs)
Number of subjects: 186
Study: 34676440

Group type: EXPERIMENTAL
Intervention: Methylphenidate (20 mg, oral)
Number of subjects: 102
Study: 36208361

Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 361
Study: 33755227

Group type: EXPERIMENTAL
Intervention: Chlorella water extract (CWE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 32234652

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) plus probiotics (Bifidobacterium longum BB536, Lactobacillus rhamnosus HN001) for 4 months (n = 16)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Mediterranean diet (MD) alone for 4 months (n = 18)
Number of subjects: 34
Study: 35821019

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel/cisplatin (AP)
Number of subjects: 254

Group type: COMPARATOR
Intervention: gemcitabine/cisplatin (GP)
Number of subjects: 254
Study: 33216002

Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive behavioral therapy (TCBT); n=17 at 3 months and n=13 at 12 months
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Web-based cognitive behavioral therapy (WCBT); n=17 at 3 months and n=12 at 12 months
Number of subjects: 34
Study: 35659264

Group type: EXPERIMENTAL
Intervention: Time Out consultation (TOC) with the general practitioner (GP) and follow-up by a home care oncology nurse (HON)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 154
Study: 32058444

Group type: EXPERIMENTAL
Intervention: 4-hour repositioning combined with a viscoelastic foam mattress
Number of subjects: 1204

Group type: COMPARATOR
Intervention: 2-hour repositioning combined with a powered air pressure redistribution mattress
Number of subjects: 1204
Study: 34000119

Group type: EXPERIMENTAL
Intervention: Complicated Grief Treatment (CGT) with placebo
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: CGT plus citalopram
Number of subjects: 395

Group type: COMPARATOR
Intervention: Citalopram
Number of subjects: 395

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 395
Study: 33248586

Group type: EXPERIMENTAL
Intervention: Feed formulation with 60% CP soybean meal (SBM)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Increased feed crumble particle size with fewer fines in starter feed
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dietary enzyme cocktail (Rovabio Advance)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Reduced feed fines without dietary enzyme cocktail
Number of subjects: 120
Study: 35647715

Group type: EXPERIMENTAL
Intervention: Multiple-exemplar training, prompting, and social reinforcement
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study: 33256621

Group type: EXPERIMENTAL
Intervention: Rituximab and maintenance Mycophenolate mofetil (1200 mg/m2 per day starting 3 months after Rituximab)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Repeated courses of prophylactic Rituximab (administered at 0, 8 and 16 months if B cell count normalizes)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 100
Study: 32295049

Group type: EXPERIMENTAL
Intervention: Salt iodization policy
Number of subjects: 18864

Group type: EXPERIMENTAL
Intervention: Nutritional status measured by BMI
Number of subjects: 18864
Study: 36325128

Group type: EXPERIMENTAL
Intervention: High dose pistachios (3.0 oz/d; PH)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (water only)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low dose pistachios (1.5 oz/d; PL)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Pistachios (both doses)
Number of subjects: 27
Study: 32045501

Group type: EXPERIMENTAL
Intervention: High-dose baclofen (75 mg/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Low-dose baclofen (30 mg/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 34134947

Group type: EXPERIMENTAL
Intervention: Aromatherapy (AT)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Combination Therapy (CT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 160
Study: 32034474

Group type: EXPERIMENTAL
Intervention: Self‐made drainage tubes with a small diameter (outer diameter 2.0 mm, inner diameter 1.0 mm)
Number of subjects: 153

Group type: COMPARATOR
Intervention: No. 8 tubes
Number of subjects: 153
Study: 35637140

Group type: EXPERIMENTAL
Intervention: Active retrieval (writing down the steps from memory for 15 minutes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Passive studying (reading the steps)
Number of subjects: 50
Study: 33451603

Group type: COMPARATOR
Intervention: Surgical staples
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Subcuticular suture
Number of subjects: 232
Study: 32532222

Group type: EXPERIMENTAL
Intervention: Automated classification algorithm
Number of subjects: 102

Group type: COMPARATOR
Intervention: Neurologist classification
Number of subjects: 102
Study: 36243123

Group type: EXPERIMENTAL
Intervention: 5% dextrose PrT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15% dextrose PrT
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% saline injections
Number of subjects: 60
Study: 33573767

Group type: EXPERIMENTAL
Intervention: Nudge strategies embedded within an enhanced invitation
Number of subjects: 88

Group type: COMPARATOR
Intervention: Generic invitation
Number of subjects: 88
Study: 33278138

Group type: EXPERIMENTAL
Intervention: Use of grafts in frontal sinus drill-outs
Number of subjects: 0
Study: 32194148

Group type: EXPERIMENTAL
Intervention: Thiazolidinediones
Number of subjects: 41871

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 41871

Group type: EXPERIMENTAL
Intervention: PERR Pairwise estimates for thiazolidinediones
Number of subjects: 41871

Group type: COMPARATOR
Intervention: ADOPT trial
Number of subjects: 41871
Study: 36379883

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 1g before incision, followed by 125mg/h infusion
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 218
Study: 34475164

Group type: EXPERIMENTAL
Intervention: Higher relationship satisfaction
Number of subjects: 547
Study: 32378726

Group type: EXPERIMENTAL
Intervention: High-intensity arm resistance training (HIT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Low-intensity arm resistance training (LIT)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both HIT and LIT
Number of subjects: 43
Study: 35119235

Group type: EXPERIMENTAL
Intervention: 980nm diode laser
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cold scalpel
Number of subjects: 60
Study: 34164367

Group type: EXPERIMENTAL
Intervention: Short nap + normal indoor light (100 lx, 4,000 K at eye level)
Number of subjects: 17

Group type: COMPARATOR
Intervention: No nap + normal indoor light
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: No nap + blue-enriched bright light (1,000 lx, 6,500 K at eye level)
Number of subjects: 17
Study: 34448219

Group type: EXPERIMENTAL
Intervention: Single 6-mm implant with a cantilever (ONE-C)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Two 6-mm implants (TWO)
Number of subjects: 36
Study: 35932397

Group type: EXPERIMENTAL
Intervention: SHUTi-OASIS (Internet-delivered cognitive behavioral therapy for insomnia)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Patient Education (control group)
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: SHUTi-OASIS
Number of subjects: 311

Group type: COMPARATOR
Intervention: Patient Education
Number of subjects: 311
Study: 32959588

Group type: EXPERIMENTAL
Intervention: Wentong acupuncture
Number of subjects: 128

Group type: COMPARATOR
Intervention: Vitamin D calcium chewable tablets (0.6 g, once a day) and calcitriol capsules (0.25 μg, three times a day)
Number of subjects: 128
Study: 33258162

Group type: EXPERIMENTAL
Intervention: HPMC-based films with 0.1% DL-α-tocopherol acetate (VE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SPI-based films with 0.25% oleic acid and 0.1% VE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPMC films
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SPI-based pouch after 60 days of storage at 35 °C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPMC/2% CNC film
Number of subjects: 0
Study: 32515888

Group type: EXPERIMENTAL
Intervention: Year-long telephone-delivered lifestyle support by health professionals
Number of subjects: 2607

Group type: COMPARATOR
Intervention: Control group (no lifestyle intervention)
Number of subjects: 2607
Study: 35461434

Group type: EXPERIMENTAL
Intervention: COLD (ice-cold water 0-3 °C)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: WARM (warm water 45 °C)
Number of subjects: 14

Group type: COMPARATOR
Intervention: ROOM (room temperature water 20 °C)
Number of subjects: 14
Study: 33141616

Group type: EXPERIMENTAL
Intervention: CEE (oral conjugated equine estrogens)
Number of subjects: 934

Group type: EXPERIMENTAL
Intervention: CEE+MPA (oral conjugated equine estrogens and medroxyprogesterone acetate)
Number of subjects: 934

Group type: EXPERIMENTAL
Intervention: CEE
Number of subjects: 934

Group type: EXPERIMENTAL
Intervention: CEE+MPA
Number of subjects: 934

Group type: EXPERIMENTAL
Intervention: Subset of 4 metabolites (C58:11 triacylglycerol, C54:9 triacylglycerol, C36:1 phosphatidylcholine, sucrose)
Number of subjects: 934
Study: 36096775

Group type: EXPERIMENTAL
Intervention: HPV PROTECT intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Provider perspectives regarding intervention feasibility, acceptability, and appropriateness
Number of subjects: 0
Study: 34297008

Group type: EXPERIMENTAL
Intervention: Behavioral hypnotic suggestibility
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Nonhypnotic suggestibility
Number of subjects: 135
Study: 36115667

Group type: EXPERIMENTAL
Intervention: Local treatment with gentamicin (80 mg), vancomycin (1 g), and cefazolin (1 g) dissolved in 500 mL of isotonic saline.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo solution of 500 mL isotonic saline.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local treatment with gentamicin, vancomycin, and cefazolin.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo solution of isotonic saline.
Number of subjects: 0
Study: 33452045

Group type: EXPERIMENTAL
Intervention: CSCI-furosemide (average daily dose 125 mg, duration 10 days)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: CSCI-furosemide
Number of subjects: 116
Study: 35791582

Group type: EXPERIMENTAL
Intervention: Urokinase plus tirofiban
Number of subjects: 96

Group type: COMPARATOR
Intervention: Urokinase
Number of subjects: 96
Study: 32647367

Group type: EXPERIMENTAL
Intervention: 30 g whole flaxseed powder
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 1 g hesperidin supplementation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 30 g flaxseed and 1 g hesperidin (flax‐hes)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lifestyle modification program (control)
Number of subjects: 100
Study: 34081648

Group type: EXPERIMENTAL
Intervention: Telerehabilitation training provided by a low vision therapist
Number of subjects: 57

Group type: COMPARATOR
Intervention: Self-training standard offered by the device manufacturer (control group)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both telerehabilitation and self-training
Number of subjects: 57
Study: 32524803

Group type: EXPERIMENTAL
Intervention: Cognitive remediation combined with therapeutic education
Number of subjects: 80

Group type: COMPARATOR
Intervention: Cognitive remediation
Number of subjects: 80
Study: 36066459

Group type: EXPERIMENTAL
Intervention: Vedolizumab (early PMS remission)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Adalimumab (early PMS remission)
Number of subjects: 257
Study: 33941170

Group type: EXPERIMENTAL
Intervention: Laypeople using a manual toothbrush
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Laypeople using a powered toothbrush
Number of subjects: 39

Group type: COMPARATOR
Intervention: Dental professionals using a manual toothbrush
Number of subjects: 39

Group type: COMPARATOR
Intervention: Dental professionals using a powered toothbrush
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Laypeople (all groups)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Powered toothbrush (all groups)
Number of subjects: 39
Study: 32000176

Group type: EXPERIMENTAL
Intervention: Social Skills Intervention Program
Number of subjects: 12

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 12
Study: 33047116

Group type: EXPERIMENTAL
Intervention: OPG knockdown in HESCs
Number of subjects: 31

Group type: COMPARATOR
Intervention: Inhibition of Akt activation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Syndecan-1 knockdown
Number of subjects: 31

Group type: COMPARATOR
Intervention: Comparison of OPG and Syndecan-1 expression
Number of subjects: 31
Study: 34246238

Group type: EXPERIMENTAL
Intervention: Functional disability measured by the PROMIS® Physical Function Short Form‐20 T-score
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Functional disabilities in instrumental activities of daily living, self-care activities, and functional mobility
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Presence of musculoskeletal conditions of high impact in functional disability
Number of subjects: 211
Study: 32389587

Group type: EXPERIMENTAL
Intervention: HPV detection using real-time PCR and other confirmatory methods
Number of subjects: 62

Group type: COMPARATOR
Intervention: Positive controls for HPV detection
Number of subjects: 62

Group type: COMPARATOR
Intervention: Negative controls for HPV detection
Number of subjects: 62
Study: 33491619

Group type: EXPERIMENTAL
Intervention: Recommended first aid practices
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Potentially harmful practices
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Reporting only recommended practices
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Reporting only potentially harmful practices
Number of subjects: 357
Study: 36418143

Group type: EXPERIMENTAL
Intervention: HIV self-testing alongside edutainment comics
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: HIV self-testing alone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Edutainment comic alone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 120
Study: 32401106

Group type: EXPERIMENTAL
Intervention: Elastic abdominal binder
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control (no abdominal binder)
Number of subjects: 180
Study: 35508053

Group type: EXPERIMENTAL
Intervention: Sonothrombolysis and primary coronary angioplasty
Number of subjects: 100

Group type: COMPARATOR
Intervention: Primary coronary angioplasty
Number of subjects: 100
Study: 32991429

Group type: EXPERIMENTAL
Intervention: TPF-based induction chemotherapy (IC) regimen
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: TP-based induction chemotherapy (IC) regimen
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: GP-based induction chemotherapy (IC) regimen
Number of subjects: 206
Study: 33179847

Group type: EXPERIMENTAL
Intervention: Abdominal massage
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 33999765

Group type: EXPERIMENTAL
Intervention: Parous women
Number of subjects: 5412

Group type: EXPERIMENTAL
Intervention: Number of childbirths
Number of subjects: 5412

Group type: EXPERIMENTAL
Intervention: Higher age at first birth
Number of subjects: 5412

Group type: EXPERIMENTAL
Intervention: Age at first or last birth
Number of subjects: 5412
Study: 33355063

Group type: EXPERIMENTAL
Intervention: CBT focused on perfectionism (CBT‐P)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Unified protocol for the transdiagnostic treatment of emotional disorders (UP)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 75
Study: 36425571

Group type: EXPERIMENTAL
Intervention: 900 mg Nigella sativa (450 mg soft gelatin capsules twice daily for two weeks)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 2,000 IU of vitamin D3 (1000-IU tablets, two tablets once daily)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 900 mg Nigella sativa and 2,000 IU of vitamin D3 (same dosing as previous groups)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of Nigella sativa and vitamin D3
Number of subjects: 120

Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 120
Study: 34362779

Group type: EXPERIMENTAL
Intervention: Dietary guidance group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Restricted diet group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (normal diet)
Number of subjects: 60
Study: 33217726

Group type: EXPERIMENTAL
Intervention: Whole-body cold-water immersion (cooling) after training sessions for 10 minutes.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Passive sitting (control) after training sessions for 10 minutes.
Number of subjects: 11
Study: 33129356

Group type: EXPERIMENTAL
Intervention: Unified protocol for the transdiagnostic treatment of emotional disorders (n = 35)
Number of subjects: 70
Study: 35279873

Group type: EXPERIMENTAL
Intervention: GTCs 540 mg plus vitamin C 50 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: UVR-exposed skin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Unexposed skin
Number of subjects: 50
Study: 32660488

Group type: EXPERIMENTAL
Intervention: Transanal Minimally Invasive Surgery (TAMIS)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Endoscopic Submucosal Dissection (ESD)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: TAMIS and ESD
Number of subjects: 198
Study: 35914929

Group type: EXPERIMENTAL
Intervention: Pioglitazone (PGZ)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80